GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

GLP-1 receptor agonists are not associated with increased risks for dry age-related macular degeneration or cataract ...

The global health organization now officially backs drugs like Wegovy for obesity management. But it might be more symbolic ...

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...

By Tashi McQueenAFRO Staff [email protected] Type 2 diabetes mellitus (T2DM) is a chronic, life-altering condition affecting more than 35 million Americans. The disease occurs when a person’s ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way ...

Demand for GLP-1 medicines is rising, but health authorities warn against uncritical use. The post Rising demand raises ...

Researchers profiled a terminally sterilized probiotic-fermented MFH beverage and identified aporphine alkaloids and ...

GLP-1 side effects like constipation and muscle mass loss can lead to uncomfortable pelvic floor symptoms like bladder ...

The coexistence of type 2 diabetes and obesity represents a major global health challenge that significantly increases cardiovascular and metabolic risk.

Regular exercise and sufficient protein intake can help maintain muscle and preserve long-term health in patients taking ...